002783.SZ
Hubei Kailong Chemical Group Co., Ltd.
SZSE · Basic Materials · C 制造业 · CN
CNY 7.77
−0.64%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 3.5B | 3.5B | 3.7B | 3.8B | 3.4B |
| Cost of Revenue | 2.4B | 2.5B | 2.6B | 2.7B | 2.6B |
| Gross Profit | 1.1B | 1.1B | 1.1B | 1.0B | 814.5M |
| Operating Expenses | |||||
| R&D Expense | 95.1M | 98.4M | 87.6M | 80.7M | 66.9M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 398.6M | 384.2M | 413.0M | 350.5M | 312.5M |
| Selling & Marketing Expense | 138.9M | 126.5M | 116.2M | 94.3M | 77.3M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 756.7M | 735.0M | 771.7M | 707.7M | 630.7M |
| Cost and Expenses | 3.2B | 3.2B | 3.4B | 3.5B | 3.2B |
| Operating Income (EBIT) | 311.5M | 355.4M | 347.0M | 330.3M | 181.4M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 310.1M | 353.8M | 290.8M | 302.8M | 188.9M |
| Income Tax Expense | 97.3M | 106.7M | 34.3M | 55.9M | 33.2M |
| Bottom Line | |||||
| Net Income | 116.1M | 142.4M | 148.2M | 175.4M | 133.3M |
| Earnings from Cont. Ops | 212.8M | 247.1M | 256.5M | 246.9M | 155.7M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 116.1M | 142.4M | 148.2M | 175.4M | 133.3M |
| Per Share | |||||
| Basic EPS | CN¥0.23 | CN¥0.29 | CN¥0.32 | CN¥0.45 | CN¥0.35 |
| Diluted EPS | CN¥0.23 | CN¥0.29 | CN¥0.32 | CN¥0.45 | CN¥0.35 |
| Revenue Per Share | CN¥7.25 | CN¥7.22 | CN¥7.96 | CN¥9.70 | CN¥8.94 |
| Shares | |||||
| Basic Shares Outstanding | 482.3M | 491.1M | 463.0M | 389.7M | 380.9M |
| Diluted Shares Outstanding | 482.3M | 491.1M | 463.0M | 389.7M | 380.9M |
| Profitability Metrics | |||||
| EBITDA | — | 720.1M | 693.9M | 671.2M | 472.4M |
| D&A | — | 364.8M | 346.9M | 340.8M | 291.0M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026